Blood Stem Cell Transplant Failure
8
0
0
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
25.0%
2 terminated out of 8 trials
71.4%
-15.1% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Haplo Peripheral Blood Sct In GVHD Prevention
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
The Effect of Nursing Education on Oral Mucositis in Bone Marrow Transplant Patients
Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.
Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
Long Term Minor Sibling Donor Well-Being